241
Views
2
CrossRef citations to date
0
Altmetric
Clinical features - Original research

Antibiotics’ susceptibility patterns of bacterial isolates causing lower respiratory tract infections in ICU patients at referral hospitals in Namibia

ORCID Icon, ORCID Icon & ORCID Icon
Pages 356-363 | Received 24 Jul 2021, Accepted 25 Aug 2021, Published online: 09 Sep 2021

References

  • Troeger C, Blacker B, Khalil IA et al. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: a systematic analysis for the global burden of disease study 2016. Lancet Infect Dis. 2018;18(11):1191–1210.
  • Reiner RC, Welgan CA, Casey DC, et al. Identifying residual hotspots and mapping lower respiratory infection morbidity and mortality in African children from 2000 to 2017. Nat Microbiol. 2019;4(12):2310–2318.
  • Troeger C, Forouzanfar M, Rao PC et al. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the global burden of disease study 2015. Lancet Infect Dis. 2017;17(11):1133–1161.
  • CDC in Namibia. Top 10 causes of death. 2020. [cited 2021 Aug 10]. Available at URL: https://www.cdc.gov/globalhealth/countries/namibia/pdf/Namibia_Factsheet.pdf.
  • Republic of namibia ministry of health and social services namibia 2012/13 health accounts report. 2015. [cited 2021 Aug 10]. Available at URL: https://www.afro.who.int/sites/default/files/2017-10/Namibia%202012-13%20Health%20Accounts%20Report%20%20%2015%20July%20%202015-FINAL.pdf.
  • Pachori P, Gothalwal R, Gandhi P. Emergence of antibiotic resistance Pseudomonas aeruginosa in intensive care unit; a critical review. Genes Dis. 2019;6(2):109–119.
  • Khan S, Priti S, Ankit S. Bacteria etiological agents causing lower respiratory tract infections and their resistance patterns. Iran Biomed J. 2015;19(4):240–246.
  • CDC. Pneumonia can be prevented—vaccines can help. 2020. [cited 2021 Aug 10]. Available at URL: https://www.cdc.gov/pneumonia/prevention.html.
  • Godman B, Egwuenu A, Haque M, et al. Strategies to improve antimicrobial utilization with a special focus on developing countries. Life. 2021;11(6):528.
  • Jacobs MR, Felmingham D, Appelbaum PC, et al. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. J Antimicrob Chemother. 2003;52(2):229–246.
  • Gupta S, Khan W, Krishna A. Pattern of skin diseases and common drugs prescribed in dermatology OPD of an Indian tertiary care hospital. Int J Basic Clin Pharmacol. 2016;6(1):203–207
  • Brusselaers N, Vogelaers D, Blot S. The rising problem of antimicrobial resistance in the intensive care unit. Ann Intensive Care. 2011;1(1):47.
  • Zilahi G, Artigas A, Martin-Loeches I. What’s new in multidrug-resistant pathogens in the ICU? Ann Intensive Care. 2016;6(1):96.
  • Bernabe KJ, Langendorf C, Ford N, et al. Antimicrobial resistance in West Africa: a systematic review and meta-analysis. Int J Antimicrob Agents. 2017;50(5):629–639.
  • Leopold SJ, van Leth F, Tarekegn H, et al. Antimicrobial drug resistance among clinically relevant bacterial isolates in sub-Saharan Africa: a systematic review. J Antimicrob Chemother. 2014;69(9):2337–2353.
  • Agaba P, Tumukunde J, Tindimwebwa JVB, et al. Nosocomial bacterial infections and their antimicrobial susceptibility patterns among patients in Ugandan intensive care units: a cross sectional study. BMC Res Notes. 2017;10(1):349.
  • Founou RC, Founou LL, Essack SY. Clinical and economic impact of antibiotic resistance in developing countries: a systematic review and meta-analysis. PloS One. 2017;12(12):e0189621.
  • Cassini A, Hogberg LD, Plachouras D, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19(1):56–66.
  • Godman B, Haque M, McKimm J, et al. Ongoing strategies to improve the management of upper respiratory tract infections and reduce inappropriate antibiotic use particularly among lower and middle-income countries: findings and implications for the future. Curr Med Res Opin. 2020;36(2):301–327.
  • Sánchez-Velázquez LD. Ponce de León Rosales S, Rangel Frausto MS. The burden of nosocomial infection in the intensive care unit: effects on organ failure, mortality and costs. A nested case-control study. Archives of medical research. 2006;37(3):370–375.
  • Dasgupta S, Das S, Chawan NS, et al. Nosocomial infections in the intensive care unit: incidence, risk factors, outcome and associated pathogens in a public tertiary teaching hospital of Eastern India. Indian J Crit Care Med. 2015;19(1):14–20.
  • Rosenthal VD, Maki DG, Salomao R, et al. Device-associated nosocomial infections in 55 intensive care units of 8 developing countries. Ann Intern Med. 2006;145(8):582–591.
  • Kalanuria AA, Ziai W, Mirski M. Ventilator-associated pneumonia in the ICU. Crit Care. 2014;18(2):208.
  • Kollef MH, Hamilton CW, Ernst FR. Economic impact of ventilator-associated pneumonia in a large matched cohort. Infect Control Hosp Epidemiol. 2012;33(3):250–256.
  • Feng DY, Zhou YQ, Zhou M, et al. Risk factors for mortality due to ventilator-associated pneumonia in a Chinese hospital: a retrospective study. Med Sci Monit. 2019;25:7660–7665.
  • Guillamet MCV, Burnham JP, Kollef MH. Novel approaches to hasten detection of pathogens and antimicrobial resistance in the intensive care unit. Semin Respir Crit Care Med. 2019;40(4):454–464.
  • Timsit JF, Bassetti M, Cremer O, et al. Rationalizing antimicrobial therapy in the ICU: a narrative review. Intensive Care Med. 2019;45(2):172–189.
  • Kollef MH, Fraser VJ. Antibiotic resistance in the intensive care unit. Ann Intern Med. 2001;134(4):298–314.
  • Nusrat T, Akter N, Rahman NAA, et al. Antibiotic resistance and sensitivity pattern of Metallo-β-Lactamase producing gram-Negative Bacilli in ventilator-associated pneumonia in the intensive care unit of a public medical school hospital in Bangladesh. Hospital practice. 2020;48(3):128–136.
  • Nakwatumbah S, Kibuule D, Godman B, et al. Compliance to guidelines for the prescribing of antibiotics in acute infections at Namibia’s national referral hospital: a pilot study and the implications. Expert Rev Anti Infect Ther. 2017;15(7):713–721.
  • Niaz Q, Godman B, Campbell S, et al. Compliance to prescribing guidelines among public health care facilities in Namibia; findings and implications. Int J Clin Pharm. 2020;42(4):1227–1236.
  • Mwita JC, Ogunleye OO, Olalekan A, et al. Key issues surrounding appropriate antibiotic use for prevention of surgical site infections in low- and middle-income countries: a narrative review and the implications. Int J Gen Med. 2021;14:515–530.
  • Sefah IA, Essah DO, Kurdi A, et al. Assessment of adherence to pneumonia guidelines and its determinants in an ambulatory care clinic in Ghana: findings and implications for the future. JAC Antimicrob Resist. 2021;3(2):dlab080.
  • De Bruycker M, Van den Bergh R, Dahmane A, et al. Non-adherence to standard treatment guidelines in a rural paediatric hospital in Sierra Leone. Public Health Action. 2013;3(2):118–124.
  • Gasson J, Blockman M, Willems B. Antibiotic prescribing practice and adherence to guidelines in primary care in the cape town metro district, South Africa. South Afr Med J. 2018;108(4):304–310.
  • Mengistu A, Gaeseb J, Uaaka G, et al. Antimicrobial sensitivity patterns of cerebrospinal fluid (CSF) isolates in Namibia: implications for empirical antibiotic treatment of meningitis. J Pharm Policy Pract. 2013;6(1):4.
  • WHO. WHONET Software Version 5.6. 2020. Available at URL: https://www.whonet.org/software.html.
  • WHO Africa Region. Disease Surveillance and Response Programme Area - Disease Prevention and Control Cluster. Guide for establishing laboratory-based surveillance for antimicrobial resistance. 2013. Available at URL: https://www.afro.who.int/sites/default/files/2017-06/guide-for-establishing-lab-based-surveillance-for-amr.pdf
  • Claeys KC, Zasowski EJ, Trinh TD, et al. Antimicrobial stewardship opportunities in critically ill patients with gram-negative lower respiratory tract infections: a multicenter cross-sectional analysis. Infect Dis Ther. 2018;7(1):135–146.
  • Peneş NO, Muntean AA, Moisoiu A, et al. An overview of resistance profiles ESKAPE pathogens from 2010-2015 in a tertiary respiratory center in Romania. Romanian journal of morphology and embryology. 2017;58(3): 909–922
  • Negm EM, Mowafy SMS, Mohammed AA, et al. Antibiograms of intensive care units at an Egyptian tertiary care hospital. The Egyptian Journal of Bronchology. 2021;15(1):15.
  • Senbayrak Akcay S, Inan A, Cevan S, et al. Gram-negative bacilli causing infections in an intensive care unit of a tertiary care hospital in Istanbul, Turkey. J Infect Developing Countries. 2014;8(5):597–604.
  • Aruhomukama D, Najjuka CF, Kajumbula H, et al. bla(VIM)- and bla(OXA)-mediated carbapenem resistance among Acinetobacter baumannii and Pseudomonas aeruginosa isolates from the Mulago hospital intensive care unit in Kampala, Uganda. BMC Infect Dis. 2019;19(1):853.
  • Perovic O, Ismail H, Quan V, et al. Carbapenem-resistant Enterobacteriaceae in patients with bacteraemia at tertiary hospitals in South Africa, 2015 to 2018. Eur J Clin Microbiol Infect Dis. 2020;39(7):1287–1294.
  • Kuster SP, Ruef C, Zbinden R, et al. Stratification of cumulative antibiograms in hospitals for hospital unit, specimen type, isolate sequence and duration of hospital stay. J Antimicrob Chemother. 2008;62(6):1451–1461.
  • CDC. Laboratory Testing - Methicillin-resistant Staphylococcus aureus (MRSA). 2019. [cited 2021 Aug 10]. Available from URL: https://www.cdc.gov/mrsa/lab/index.html
  • Langford BJ, So M, Raybardhan S, et al. Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis. Clin Microbiol Infect. 2021;27(4):520–531.
  • Hsu J. How covid-19 is accelerating the threat of antimicrobial resistance. BMJ. 2020;369:m1983.
  • Moretto F, Sixt T, Devilliers H, et al. Is there a need to widely prescribe antibiotics in patients hospitalized with COVID-19? Inter J Infect Dis. 2021;105:256–260.
  • Langford BJ, So M, Raybardhan S, et al. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect. 2020;26(12):1622–1629.
  • Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062.
  • Krause KM, Serio AW, Kane TR, et al. Aminoglycosides: an Overview. Cold Spring Harb Perspect Med. 2016;6(6):6.
  • Woodhead M, Blasi F, Ewig S, et al. Guidelines for the management of adult lower respiratory tract infections–full version. Clin Microbiol Infect. 2011;17(Suppl6):E1–59.
  • Lippincott’s Illustrated Reviews Pharmacology -. 2009. Book (Pharma). 4th ed. Lippincott Williams & Wilkins. ISBN: 978-0-7817-7155-9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.